INDV 8-K 2026-11-02

Indivior Pharmaceuticals, Inc. (INDV) 8-K dated 2026-11-02 — accession 0001104659-26-121013.

Indivior Pharmaceuticals, Inc. (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Indivior Pharmaceuticals, Inc. filed a 8-K on 2026-11-02. Accession 0001104659-26-121013.

This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), New debt obligation (Item 2.03), Director/officer change (Item 5.02), Bylaws or fiscal year change (Item 5.03), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B.

Not investment advice. The INDV SEC hub lists recent forms. The stock page is the research view.